Rapidly Emerging Antiviral Drug Development Initiative (READDI)

United States of America (USA)

1 December 2019 - 30 November 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Rapidly Emerging Antiviral Drug Development Initiative (READDI) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
3 0.07

Outputs by subject (Share)

Subject Count Share
Life Sciences 3 0.07
1 0.04
1 0.01
1 0.02

1 December 2019 - 30 November 2020

International vs. domestic collaboration by Share

  • 100% Domestic
  • 0% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (4 total)

  • Rapidly Emerging Antiviral Drug Development Initiative (READDI), United States of America (USA)
  • Domestic institution
  1. Eiger BioPharmaceuticals, Inc., United States of America (USA) (0.12)
    0.01
    0.11
  2. Pacific Northwest National Laboratory (PNNL), United States of America (USA) (0.10)
    0.02
    0.07
  3. Stanford University, United States of America (USA) (0.05)
    0.01
    0.04
  4. U.S. Department of Veterans Affairs, United States of America (USA) (0.03)
    0.01
    0.02

Top 10 international collaborators by Share (0 total)

  • Rapidly Emerging Antiviral Drug Development Initiative (READDI), United States of America (USA)
  • Foreign institution

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs